Literature DB >> 25646915

The importance of accounting for immortal time bias in pharmacoepidemiologic analyses.

Laura Targownik1.   

Abstract

Mesh：

Year:  2015        PMID： 25646915     DOI： 10.1038/ajg.2014.372

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  2 in total

Review 1.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

2.  Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.

Authors:  Fernando Magro; Eduardo Rodrigues-Pinto; Rosa Coelho; Patrícia Andrade; João Santos-Antunes; Susana Lopes; Claudia Camila-Dias; Guilherme Macedo
Journal:  Am J Gastroenterol       Date:  2014-05-06       Impact factor: 10.864
  2 in total
  2 in total

1.  Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.

Authors:  Laura E Targownik; Samy Suissa
Journal:  Am J Gastroenterol       Date:  2015-09-01       Impact factor: 10.864

2.  Response to Targownik.

Authors:  Fernando Magro; Eduardo Rodrigues-Pinto; Rosa Coelho; Patrícia Andrade; João Santos-Antunes; Susana Lopes; Claudia Camila-Dias; Guilherme Macedo
Journal:  Am J Gastroenterol       Date:  2015-02       Impact factor: 10.864
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.